[1]Raju,C.M.Haricharan;Lakshmi,P.Naga;Srinivas;Reddy;Acharyulu,PalleV.R.[SyntheticCommunications,2005,vol.35,#2,p.209-212]
[2]HaricharanRaju;Anand,C.Vijay;Dubey;Acharyulu,PalleV.R.[IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2007,vol.46,#1,p.170-172]
[3]CurrentPatentAssignee:DICCORP.-US2019/62256,2019,A1Locationinpatent:Paragraph0157-0162
[4]CurrentPatentAssignee:DICCORP.-TW2019/12621,2019,ALocationinpatent:Paragraph0215-0218
[1]HaricharanRaju;Anand,C.Vijay;Dubey;Acharyulu,PalleV.R.[IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2007,vol.46,#1,p.170-172]
[1]CurrentPatentAssignee:ABNYNAESPETROLEUM-US4150137,1979,A
[1]CurrentPatentAssignee:TAKASAGOINTERNATIONALCORPORATION-US2016/2268,2016,A1Locationinpatent:Paragraph0200
[1]Zhou,Xin-Yue;Zhang,Ming;Liu,Zhong;He,Jia-Hao;Wang,Xiao-Chen[JournaloftheAmericanChemicalSociety,2022,vol.144,#32,p.14463-14470]
Title: Inhibitory activity of CX-659S, a novel diaminouracil derivative, against the rebound phenomenon following withdrawal of corticosteroid therapy for chronic contact hypersensitivity responses.
Journal: International archives of allergy and immunology 20030601
Title: Pesheck CV, et al. Preformulation characterization of topical Ibuprofen Piconol. Drug Development and Industrial Pharmacy Vol. 19 , Iss. 15,1993
Title: Christensen JM, et al. Ibuprofen piconol hydrolysis in vitro in plasma, whole blood, and serum using different anticoagulants. J Pharm Sci. 1991 Jan;80(1):29-31.
